BLS Pharmaceuticals Ltd

NEW
ASX:BLS (Australia)  
A$ 0.97 (0%) Jul 14
26.22
P/B:
10.66
Market Cap:
A$ 223.08M ($ 154.56M)
Enterprise V:
A$ 220.84M ($ 153.01M)
Volume:
392.81K
Avg Vol (2M):
373.70K
Trade In:
Volume:
392.81K
Avg Vol (2M):
373.70K

BLS Pharmaceuticals Ltd (ASX:BLS) Dividend

BLS Pharmaceuticals Ltd (ASX:BLS) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -50.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:BLS Dividend

Does BLS Pharmaceuticals Ltd (ASX:BLS) pay a dividend?

BLS Pharmaceuticals Ltd (ASX:BLS) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BLS Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BLS Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -50.1% over the past 3 years.

What are dividend-paying alternatives to BLS Pharmaceuticals Ltd?

For dividend-paying alternatives in BLS Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.